{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:16:40Z","timestamp":1794291400732,"version":"4.9.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["U3CRH33332"],"award-info":[{"award-number":["U3CRH33332"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.drugalcdep.2025.112628","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T11:32:21Z","timestamp":1740828741000},"page":"112628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The opioid epidemic in rural communities: Can telehealth increase access to medications for opioid use disorder and offset barriers to care?"],"prefix":"10.1016","volume":"271","author":[{"given":"Kathleen","family":"Meyers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0781-1215","authenticated-orcid":false,"given":"Shannon","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2790-2288","authenticated-orcid":false,"given":"Heather","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bresani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Koban","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"63","key":"10.1016\/j.drugalcdep.2025.112628_bib1","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.amepre.2018.02.006","article-title":"Prescribing practices of rural physicians waivered to prescribe buprenorphine","volume":"54","author":"Andrilla","year":"2018","journal-title":"Am. J. Prev. Med"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112628_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jrh.12307","article-title":"Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update","volume":"35","author":"Andrilla","year":"2019","journal-title":"J. Rural Health"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib3","series-title":"Medicare beneficiary use of telehealth visits: Early data from the start of COVID-19 pandemic","author":"Bosworth","year":"2020"},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112628_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1176\/appi.ajp.20220312","article-title":"Risk of experiencing an overdose event for patients undergoing treatment with medication for opioid use disorder","volume":"180","author":"Brandt","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib5","series-title":"APA Handbook of Research Methods in Psychology, Vol 2: Research Designs: Quantitative, Qualitative, Neuropsychological, and Biological","first-page":"57","article-title":"Thematic analysis","author":"Braun","year":"2012"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib6","article-title":"Patient-centered telehealth solution for observed urine collections in substance use disorder care delivery during COVID-19 and beyond","volume":"8","author":"Brett","year":"2021","journal-title":"J. Patient Exp."},{"key":"10.1016\/j.drugalcdep.2025.112628_bib7","doi-asserted-by":"crossref","first-page":"110926","DOI":"10.1016\/j.drugalcdep.2023.110926","article-title":"Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances","volume":"251","author":"Castillo","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112628_bib8","series-title":"Results from the 2020 National Survey on Drug Use and Health: Detailed tables","author":"Center for Behavioral Health Statistics and Quality (CBHSQ)","year":"2021"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib9","series-title":"Telehealth coverage policies in the time of COVID-19","author":"Center for Connected Heath Policy (CCHP)\/Public Health Institute (PHI)","year":"2021"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib10","unstructured":"Centers for Disease Control National Center for Health Statistics U.S. Overdose Deaths Decrease in 2023, First Time Since 2018 (2024) retrieved from https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm#:~:text=Provisional%20dat%20from%20CDC's%20National,111%2C029%20deaths%20estimated%20in%202022."},{"issue":"Pt B","key":"10.1016\/j.drugalcdep.2025.112628_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bpobgyn.2022.07.003","article-title":"The opioid epidemic","volume":"85","author":"Cook","year":"2022","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112628_bib12","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1353\/hpu.2020.0116","article-title":"Navigating the digital divide: barriers to telehealth in rural areas","volume":"31","author":"Cortelyou-Ward","year":"2020","journal-title":"J. Health Care Poor Under"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2017.01.048","article-title":"The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting","volume":"176","author":"Eibl","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112628_bib14","first-page":"1","article-title":"Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011-2016. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics","volume":"67","author":"Hedegaard","year":"2018","journal-title":"Natl. Vital.-. Stat. Syst."},{"issue":"11","key":"10.1016\/j.drugalcdep.2025.112628_bib15","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/jamia\/ocaa156","article-title":"Telehealth in response to the COVID-19 pandemic: Implications for rural health disparities","volume":"27","author":"Hirko","year":"2020","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"12","key":"10.1016\/j.drugalcdep.2025.112628_bib16","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1377\/hlthaff.2018.05134","article-title":"How is telemedicine being used in opioid and other substance use disorder treatment?","volume":"37","author":"Huskamp","year":"2018","journal-title":"Health Aff."},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112628_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250324","article-title":"Opioid treatment deserts: concept development and application in a US Midwestern urban county","volume":"16","author":"Hyder","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib18","first-page":"172","article-title":"COVID-19 During the opioid epidemic\u2013exacerbation of stigma and vulnerabilities","volume":"37","author":"Jenkins","year":"2021"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib19","series-title":"Qualitative Research Methods in Mental Health and Psychotherapy","first-page":"209","article-title":"Thematic Analysis","author":"Joffe","year":"2011"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112628_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsat.2013.08.009","article-title":"A randomized trial of Web-based videoconferencing for substance abuse counseling","volume":"46","author":"King","year":"2014","journal-title":"J. Subst. Abus. Treat."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112628_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.semperi.2019.01.001","article-title":"The United States opioid epidemic","volume":"43","author":"Lyden","year":"2019","journal-title":"Semin Perinatol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112628_bib22","first-page":"86","article-title":"Rural Appalachia battling the intersection of two crises: COVID-19 and substance-use disorders","volume":"2","author":"Miller","year":"2020","journal-title":"J. Appalach. Health"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib23","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences, Engineering, and Medicine","year":"2019"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib24","unstructured":"National Institute on Drug Abuse (2022, August 31). Five Areas Where \u201cMore Research\u201d Isn\u2019t Needed to Curb the Overdose Crisis. Retrieved from https:\/\/nida.nih.gov\/about-nida\/noras-blog\/2022\/08\/five-areas-where-more-research-isnt-needed-to-curb-overdose-crisis on 2025, February 14."},{"issue":"10","key":"10.1016\/j.drugalcdep.2025.112628_bib25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2105\/AJPH.2024.307745","article-title":"Trends in drug overdose deaths by intent and drug categories, United States, 1999-2022","volume":"114","author":"Nguyen","year":"2024","journal-title":"Am. J. Public Health"},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112628_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2850.2006.01033.x","article-title":"The use of telemedicine in psychiatry","volume":"13","author":"Norman","year":"2006","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"key":"10.1016\/j.drugalcdep.2025.112628_bib27","series-title":"Notification of enforcement discretion for telehealth","author":"Office for Civil Rights (OCR) at the Department of Health and Human Services (HHS)","year":"2021"},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112628_bib28","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2105\/AJPH.2021.306306a","article-title":"The effect of overdose education and naloxone distribution: an umbrella review of systematic reviews","volume":"111","author":"Razaghizad","year":"2021","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib29","article-title":"Evaluation of urine drug screen falsification of results among patients with opioid use disorder receiving treatment in a telehealth model of care","volume":"154","author":"Rollston","year":"2023","journal-title":"J. Subst. Use Addict. Treat."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112628_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13722-023-00402-0","article-title":"The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review","volume":"18","author":"Russell","year":"2023","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112628_bib31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib32","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112628_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jrh.12695","article-title":"Geographic variability in rural patient internet connectivity when accessing telehealth services from home: A retrospective analysis during the COVID-19 pandemic","volume":"39","author":"Sotzen","year":"2023","journal-title":"J. Rural Health"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib34","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA), 2020. FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency\u3008https:\/\/www.samhsa.gov\/sites\/default\/files\/faqs-for-oud-prescribing-and-dispensing.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2025.112628_bib35","unstructured":"Substance Abuse and Mental Health Services Administration, 2021. Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH, Series H-. 56). SAMHSA, Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration,https:\/\/www.samhsa.gov\/data\/."},{"key":"10.1016\/j.drugalcdep.2025.112628_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/21501319221147246","article-title":"The effect of naloxone access laws on fatal synthetic opioid overdose fatality rates","volume":"14","author":"Tabatabai","year":"2023","journal-title":"J. Prim. Care Community Health"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112628_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jama.2023.23248","article-title":"Intranasal naloxone for opioid overdose","volume":"331","author":"Taylor","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib38","unstructured":"U.S. Census Bureau. American Community Survey 5-Year data (2009\u20132021): 2016\u20132020 estimates; 2022. https:\/\/www.census.gov\/data\/developers\/data-sets\/acs-5year.html"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112628_bib39","first-page":"11","article-title":"COVID-19 and opioid use in Appalachian Kentucky: challenges and silver linings","volume":"2","author":"Vickers-Smith","year":"2020","journal-title":"J. Appalach. Health"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112628_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1172\/JCI134708","article-title":"Medications for opioid use disorders: clinical and pharmacological considerations","volume":"130","author":"Volkow","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112628_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2025.112628_bib42","series-title":"Opportunities and barriers for telemedicine in the U.S. during the COVID-19 emergency and beyond. [Issue Brief]","author":"Weigel","year":"2020"},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112628_bib43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/ajad.12805","article-title":"Expanding access to buprenorphine treatment in rural areas with the use of telemedicine","volume":"27","author":"Weintraub","year":"2018","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2025.112628_bib44","article-title":"Urine drug screening in a telehealth setting for the treatment of opioid use disorder","volume":"4","author":"Williams","year":"2023"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687162500081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687162500081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:20:48Z","timestamp":1753338048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687162500081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"alternative-id":["S037687162500081X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112628","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The opioid epidemic in rural communities: Can telehealth increase access to medications for opioid use disorder and offset barriers to care?","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112628"}}